DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
<p>Aims: To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people.</p><p>Methods and results: Econ...
Main Authors: | Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H |
---|---|
Other Authors: | The European Society of Cardiology |
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2010
|
Subjects: |
Similar Items
-
Is DNA testing for hypertrophic cardiomyopathy cost-effective?
by: Wordsworth, S, et al.
Published: (2006) -
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
by: Wordsworth, S, et al.
Published: (2010) -
Genetic Testing in Patients with Hypertrophic Cardiomyopathy
by: Jiri Bonaventura, et al.
Published: (2021-09-01) -
Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives
by: Andrea Ottaviani, et al.
Published: (2023-09-01) -
Hypertrophic Cardiomyopathy
by: Polakit Teekakirikul, MD, et al.
Published: (2021-09-01)